Mental Mental health and risk of mortality and hospitalization in COVID-19 patients. Results from the PRECOVID Study in Spain

Author:

Moreno-Juste Aida1,Poblador-Plou Beatriz1,Ortega-Larrodé Cristina2,Laguna-Berna Clara1,González-Rubio Francisca1,Aza-Pascual-Salcedo Mercedes3,Bliek-Bueno Kevin4,Padilla María5,de-la-Cámara Concepción2,Prados-Torres Alexandra1,Gimeno-Feliu Luis A6,Miguel Antonio Gimeno1

Affiliation:

1. EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón

2. Hospital Clínico Universitario Lozano Blesa

3. Primary Care Pharmacy Service Zaragoza III, Aragon Health Service (SALUD)

4. Hospital Universitario Príncipe de Asturias

5. Hospital Costa del Sol

6. San Pablo Primary Care Health Centre, Aragon Health Service (SALUD)

Abstract

Abstract The COVID-19 pandemic has created unprecedented challenges for health care systems globally. The identification of risk factors is crucial when optimizing medical resources for specific vulnerable population groups such as patients with mental disorders, who are specially at risk of poor COVID-19 outcomes. In this retrospective cohort study including 144,957 individuals with confirmed COVID-19 from the PRECOVID Study (Aragon, Spain), anxiety was the most frequent diagnosis. However, some differences were observed by sex: substance abuse, personality disorders and schizophrenia were more frequently diagnosed in men, while eating disorders, depression and mood, anxiety and cognitive disorders were more common among women. The presence of mental illness, specifically schizophrenia spectrum and cognitive disorders in men, and depression and mood disorders, substance abuse, anxiety and cognitive and personality disorders in women, increased the risk of mortality or hospitalization after COVID-19, in addition to other well-known risk factors such as age, morbidity and treatment burden. Identifying vulnerable patient profiles at risk of serious outcomes after COVID-19 based on their mental health status will be crucial to improve their access to the healthcare system and implement targeted public health prevention measures.

Publisher

Research Square Platform LLC

Reference36 articles.

1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/ (2022).

2. Dementia is a predictor for mortality outcome from coronavirus disease 2019 (COVID-19) infection;Hariyanto TI;Eur Arch Psychiatry Clin Neurosci,2021

3. Association of Psychiatric Disorders With Mortality Among Patients With COVID-19;Nemani K;JAMA Psychiatry,2021

4. Baseline Chronic Comorbidity and Mortality in Laboratory-Confirmed COVID-19 Cases: Results from the PRECOVID Study in Spain;Poblador-Plou B;Int J Environ Res Public Health,2020

5. Chronic diseases associated with increased likelihood of hospitalization and mortality in 68,913 COVID-19 confirmed cases in Spain: A population-based cohort study;Gimeno-Miguel A;PLoS One,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3